North America Non-energy Based Aesthetic Treatment Market Size, Share & Trends Analysis Report By Procedures (Injectables, Skin Rejuvenation), By End-use, By Region, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1 Research Method
                   1.1 Information procurement
                   1.2 Information or Data Analysis
                   1.3 Market Formulation & Validation
Chapter 2 Executive Summary
                   2.1 Market Snapshot
Chapter 3 Market Variables, Trends & Scope
                   3.1 Market segmentation & scope
                       3.1.1 Market Driver Analysis
                       3.1.2 Market Restraint Analysis
                   3.2 North America non-energy Based aesthetic Treatment - PESTLE Analysis
                   3.3 Industry Analysis - Porter’s
                   3.4 COVID-19 Impact Analysis
Chapter 4 North America non-energy Based aesthetic Treatment Market: Procedure Estimates & Trend Analysis
                   4.1 North America non-energy Based aesthetic treatment market: Procedure movement analysis
                       4.1.1 Injectables
                           4.1.1.1 Injectables market, 2018 - 2030 (USD Million)
                           4.1.1.2 Botulinum Toxin
                               4.1.1.2.1 Botulinum toxin market, 2018 - 2030 (USD Million)
                           4.1.1.3 Calcium Hydroxylapatite
                               4.1.1.3.1 Calcium hydroxylapatite market, 2018 - 2030 (USD Million)
                           4.1.1.4 Hyaluronic Acid
                               4.1.1.4.1 Hyaluronic acid market, 2018 - 2030 (USD Million)
                           4.1.1.5 Polymer Filler
                               4.1.1.5.1 Polymer filler market, 2018 - 2030 (USD Million)
                           4.1.1.6 Collagen
                               4.1.1.6.1 Collagen market, 2018 - 2030 (USD Million)
Chapter 5 North America non-energy Based aesthetic Treatment Market: End-Use Estimates & Trend Analysis
                   5.1 North America non-energy Based aesthetic Treatment market: End-use movement analysis
                       5.1.1 Hospital/Surgery Center
                           5.1.1.1 Hospital/Surgery center market, 2018 - 2030 (USD Million)
                       5.1.2 Medspa
                           5.1.2.1 Medspa market, 2018 - 2030 (USD Million)
                       5.1.3 Traditional Spa
                           5.1.3.1 Traditional spa market, 2018 - 2030 (USD Million)
                       5.1.4 HCP owned clinic
                           5.1.4.1 HCP owned clinic market, 2018 - 2030 (USD Million)
Chapter 6 Regional Estimates & Trend Analysis, by Procedure and End-Use
                   6.1 North America non-energy Based aesthetic treatment market share by region, 2022 & 2030
                   6.2 North America
                       6.2.1 North America non-energy Based aesthetic treatment market, 2018 - 2030 (USD Million)
                       6.2.2 U.S.
                           6.2.2.1 U.S. non-energy Based aesthetic treatment market, 2018 - 2030 (USD Million)
                       6.2.3 Canada
                           6.2.3.1 Canada non-energy Based aesthetic treatment market, 2018 - 2030 (USD Million)
Chapter 7 Competitive Landscape
                   7.1 Recent Development by Key Market Players
                   7.2 Company/Competition Categorization (Key Innovators, Market Leaders)
                       7.2.1 PARTICIPANT CATEGORIZATION
                   7.3 North America non-energy Based aesthetic treatment- market share analysis
                   7.4 Company Profiles
                       7.4.1 Allergan plc (AbbVie)
                           7.4.1.1 Company overview
                           7.4.1.2 Financial performance
                           7.4.1.3 Product benchmarking
                           7.4.1.4 Strategic initiatives
                       7.4.2 Galderma
                           7.4.2.1 Company Overview
                           7.4.2.2 Financial performance
                           7.4.2.3 Product Benchmarking
                           7.4.2.4 Strategic Initiatives
                       7.4.3 Merz Pharma
                           7.4.3.1 Company Overview
                           7.4.3.2 Financial performance
                           7.4.3.3 Product benchmarking
                           7.4.3.4 Strategic initiatives
                       7.4.4 LPG SYSTEMS
                           7.4.4.1 Company overview
                           7.4.4.2 Financial performance
                           7.4.4.3 Product benchmarking
                           7.4.4.4 Strategic initiatives
                       7.4.5 NeoGenesis, Inc.
                           7.4.5.1 Company overview
                           7.4.5.2 Financial performance
                           7.4.5.3 Product benchmarking
                           7.4.5.4 Strategic initiatives
                       7.4.6 Oxygenceuticals
                           7.4.6.1 Company overview
                           7.4.6.2 Financial performance
                           7.4.6.3 Product benchmarking
                           7.4.6.4 Strategic initiatives
                       7.4.7 Genesis Biosystems, Inc.
                           7.4.7.1 Company overview
                           7.4.7.2 Product benchmarking
                       7.4.8 Revance Therapeutics, Inc.
                           7.4.8.1 Company overview
                           7.4.8.2 Financial performance
                           7.4.8.3 Product benchmarking
                           7.4.8.4 Strategic initiatives
                       7.4.9 Ipsen Pharma
                           7.4.9.1 Company overview
                           7.4.9.2 Product benchmarking
                           7.4.9.3 Strategic initiatives
                       7.4.10 Suneva Medical, Inc.
                           7.4.10.1 Company overview
                           7.4.10.2 Financial performance
                           7.4.10.3 Product benchmarking
                           7.4.10.4 Strategic initiatives
                       7.4.11 Mesoestetic Pharma Group SL
                           7.4.11.1 Company overview
                           7.4.11.2 Financial performance
                           7.4.11.3 Product benchmarking
                           7.4.11.4 Strategic initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
 

List of Figures

Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market summary (USD Million, 2022)
Fig. 7 Market trends & outlook
Fig. 8 Market segmentation & scope
Fig.9 Market driver relevance analysis (Current & future impact)
Fig. 10 Market restraint relevance analysis (Current & future impact)
Fig. 11 North America Non-energy based Aesthetic Treatment PESTLE Analysis
Fig. 12 Porter’s Five Forces Analysis
Fig. 13 COVID-19 Impact Analysis
Fig. 14 North America non-energy based aesthetic treatment market procedure outlook key takeaways
Fig. 15 North America non-energy based aesthetic treatment market: Procedure movement analysis
Fig. 16 Injectables market, 2018 - 2030 (USD Million)
Fig. 17 Botulinum toxin market, 2018 - 2030 (USD Million)
Fig. 18 Calcium hydroxyl apatite market, 2018 - 2030 (USD Million)
Fig. 19 Hyaluronic acid market, 2018 - 2030 (USD Million)
Fig. 20 Polymer filler market, 2018 - 2030 (USD Million)
Fig. 21 Collagen market, 2018 - 2030 (USD Million)
Fig. 22 Skin rejuvenation market, 2018 - 2030 (USD Million)
Fig. 23 Chemical peel market, 2018 - 2030 (USD Million)
Fig. 24 Microdermabrasion market, 2018 - 2030 (USD Million)
Fig. 25 Micro needling market, 2018 - 2030 (USD Million)
Fig. 26 North America non-energy based aesthetic treatment market end-use outlook key takeaways
Fig. 27 North America non-energy based aesthetic treatment market: End-use movement analysis
Fig. 28 Hospital/Surgery center market, 2018 - 2030 (USD Million)
Fig. 29 Med spa market, 2018 - 2030 (USD Million)
Fig. 30 Traditional spa market, 2018 - 2030 (USD Million)
Fig. 31 HCP owned clinic market, 2018 - 2030 (USD Million)
Fig. 32 Regional market place: Key takeaways
Fig. 33 Regional outlook, 2022 & 2030
Fig. 34 North America non-energy based aesthetic treatment market, 2018 - 2030 (USD Million)
Fig. 35 U.S. non-energy based aesthetic treatment market, 2018 - 2030 (USD Million)
Fig. 36 Canada non-energy based aesthetic treatment market, 2018 - 2030 (USD Million)